Bulimia Nervosa

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-07-15
Clinical Trial Update: Topiramate Augmentation in Bulimia Nervosa Partial Responders [Phase 4]
A Phase 4 clinical trial evaluating topiramate augmentation in partial responders with bulimia nervosa has been withdrawn.